BioGENext Conference 2026: Laying the ground for world-class biomedical research in Ukraine

Name: BioGENext Conference 2026: Laying the ground for world-class biomedical research in Ukraine
Start: 2026-10-06T10:00:00Z
End: 2026-10-09T15:00:00Z

Kyiv, Ukraine

October 6-9, 2026

WELCOME

The BioGENext conference 2026 is dedicated to advancing the field of next-generation therapies development. The event brings together researchers, educators, biotech companies, and industry experts to exchange knowledge and join forces to establish a strong biomedical research ecosystem in Ukraine.

The second BioGENext Conference will take place on October 6-9, 2026, in Kyiv, Ukraine. While the event will be held in a hybrid format, we strongly encourage in-person attendance as networking is a primary goal. The program features leading international and Ukrainian speakers from academia and industry and focuses on key areas shaping modern medicine, including nucleic acid therapeutics, recombinant proteins, gene editing technologies, advanced cell therapy, computational biology and AI, molecular diagnostics, and other translational research.

Abstracts submitted by participants will undergo review by the Scientific Committee and will be published in the international peer-reviewed journal "Biopolymers and Cell." Top abstract authors will have the opportunity to present orally during the main program or in a flash talk session.

The BioGENext is an initiative created by scientists and for scientists.

Our mission

We firmly believe that high-quality science and the ability to translate its results into innovative products or technologies are the key to the future development of Ukraine. Pharmaceutical biotechnology should be among the priority fields as it defines the society’s ability to resist global health challenges, as massive as pandemics and as unique as orphan diseases.

Conference Aims

1. Strengthen Biomedical Research Community. Foster deeper collaboration among Ukrainian and international researchers, biotech innovators, educators, and policymakers to build a sustainable biomedical research ecosystem in Ukraine.

2. Showcase Ukrainian Research Globally. Provide a platform for Ukrainian scientists to present impactful research and engage with international collaborators and partners.

3. Empower the Next Generation of Scientists. Support early-career researchers through educational sessions, workshops, and mentorship programs focused on emerging technologies in biomedicine and biotechnology.

4. Enhance Translational Research. Strengthen partnerships between academia and industry and promote the development of technology transfer models that enable the transition of scientific discoveries from the laboratory to therapeutic applications.

5. Shape Ukraine’s Biotechnology Strategy. Promote dialogue between academia, industry, and government to define strategic priorities for the development of the biomedical and biopharmaceutical sectors in Ukraine.

FEATURED SPEAKERS

Ben KleinstiverDr., Kayden-Lambert MGH Research Scholar. Associate Investigator, Massachusetts General Hospital. Associate Professor, Harvard Medical School, Center for Genomic Medicine & Department of Pathology, USA

Bjørn Gunnar Rude VoldborgChef Konsulent, Head of the National Biologics Facility, Department of Biotechnology and Biomedicine (DTU Bioengineering), Technical University of Denmark

Michael NishimuraProfessor, Associate Director, Cancer Center Translational Research, Program Director, Immunologic Therapeutics, Loyola University, Chicago, USA

Olha KaramanDr., Senior Researcher, Laboratory of Immunology, National Cancer Institute, Lithuania

IMPORTANT DATES:

Registration open: April 1, 2026

Abstract submissions open: April 1, 2026

Early bird abstract submission deadline: May 31, 2026

Abstract submission deadline: June 30, 2026

Early bird registration deadline: July 31, 2026

Registration deadline of In-person Type: September 28, 2026

Registration deadline of Virtual Type: October 5, 2026

PLENARY SESSION TOPICS:

Nucleic-Acid Therapeutics: Technologies and ApplicationsDevelopment of DNA- and RNA-based therapeutic solutions, including technologies for their analysis, production, and delivery. This area focuses on approaches that selectively target and modulate gene expression to enable new treatments for complex diseases such as cancer, infectious diseases, and genetic disorders.

Therapeutic Recombinant Protein Development TechnologiesDiscovery, engineering, and development of recombinant proteins and monoclonal antibodies designed to target specific molecular pathways. These technologies contribute to innovative treatments for diseases including cancer, autoimmune disorders, and metabolic conditions.

Gene Editing and Advanced Cell Technologies and Applications in MedicineResearch focused on the discovery and engineering of gene editing systems and their delivery methods. These technologies enable targeted modifications of DNA and RNA sequences and hold strong potential for treating genetic disorders and advancing personalized medicine.

Computational Biology and AI in Biomedical ResearchIntegration of computational approaches and advanced artificial intelligence frameworks to analyze biological data, providing insights into complex biological systems and supporting more efficient drug discovery and personalized medicine development.

Biomarkers and Molecular DiagnosticsIdentification and validation of molecular and genetic biomarkers associated with pathological or physiological processes, with applications in diagnostics, prognosis, and treatment decision-making.

Other Translational StudiesResearch aimed at translating fundamental scientific discoveries into clinical applications, with the goal of improving patient outcomes and advancing modern medical practice.